Alexandra Fulford (@pharmaguapa) writes: 

Pharma companies generally have a great idea of who their traditional KOLs are, but they have no idea about how active they are online (if at all) and they often have no real idea of who KOI (Key Online Influencers) are.  This is a big gap in a key knowledge area.

As more and more HCPs turn to digital the impact of KOI will become increasingly important.  Pharma companies need to start finding out which KOL are active online, and who the KOI are that they should be building relationships with them, just as they have traditionally built relationships with KOLs.

This is essentially just a new group of KOL and the process for KOL relationship development offline already exist – they  just need to be adapted for online.

See on pharmaguapa.com